ISTAR MEDICAL
Board
6 directors, 1 in day-to-day management, 1 auditor, no change since May 2026Director
current term since 31-07-2023
term until the 2026 general meeting
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 23-07-2026
Director, permanent representative
current term since 31-07-2023
term until 30-07-2027
also on the board of 25 other companies
listed in the 2025 annual accounts, filed on 23-07-2026
5 other companies bankruptDirector
since 31-07-2023
term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
Director
since 31-07-2023
term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
Director
since 16-04-2024
term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “la société est également valablement représentée par un délégué à cette gestion. La société est en outre, dans les limites de leur mandat…”deed of 17-10-2025
Permanent representatives 2
Mandates through the years
7 names, the dashed line is todayDirector
Managing director and cEO, Director
Director
Director
Director
Director
Statutory auditor
LeadershipBoardRest of the term
Mandates as a list
-
- Director, appointed by deed of 10-12-2013, still in office
-
- Managing director and cEO, appointed by deed of 23-02-2022, still in office
- Director, appointed by deed of 23-02-2022, still in office
-
- Director, appointed by deed of 02-03-2023, still in office
-
- Director, from 31-07-2023 to date
-
- Director, from 31-07-2023 to date
-
- Director, from 16-04-2024 to date
-
- Statutory auditor, appointed by deed of 01-12-2014, still in office
With Starter you also see 15 former office holders in the mandate history.
See plans →
Control
Consolidating parent
US
consolidates
This company
ISTAR MEDICAL
Equity -€23.5m
Loss €21.0m in 2025
Capital
- Capital
- €84,277,306.56
- Shares
- 226,527 in the deed of 18-11-2021
- Source
- deed of 30-06-2026
Owners through the years
as the annual accounts name themOwners as a list
-
- 2013 to 2015: 23%
- 2016: 21.7%
- 2017 to 2018: 21.2%
- 2019 to 2021: 14.2%
- 2022 to 2024: 11.6%
- 2025: 16%
-
- 2022: 14.51%
- 2025: 14.51%
-
- 2017 to 2018: 12.53%
- 2019 to 2020: 11.72%
- 2025: 13.99%
-
- 2025: 12.75%
-
- 2014: 2.29%
- 2015: 3.35%
- 2016: 4.19%
- 2017 to 2019: 2.92%
- 2020 to 2021: 2.86%
- 2022 to 2025: 2.34%
-
- 2021 to 2022: 80%
- 2023 to 2024: 0.8%
- 2025: 0.7%
-
- 2014 to 2015: 20.09%
- 2016: 19.22%
- 2017: 18.79%
- 2018: 18.57%
- 2019 to 2021: 12.03%
-
- 2016 to 2017: 0.84%
- 2018: 1.24%
- 2019 to 2020: 0.8%
-
- 2017: 4.51%
Source: parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 20-05-2026 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At most 7 directorsdeed of 20-05-2026 (in French)
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- Prix de Souscription Initial plus dividendes accumulés mais non versés divisé par Prix de Souscription Initial, tout titulaire d'Actions Privilégiées de Classe…deed of 20-05-2026 (in French)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Mêmes termes et conditions y compris déclarations et garanties de l'Offre d'Acquisition au tiers, 10.8 Obligation de suitedeed of 02-09-2019 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 15:00deed of 20-05-2026 (in French)
Shareholders
7 ownersOwners 7
- USconsolidating parentconsolidates
- Equity €15.4m Loss of €8.4m in 2025 (loss of €6.5m in 2024) Checked scoreSourceaccounts 202516%
- Equity €1.35bn Profit of €124.1m in 2025Sourceaccounts 202514.51%
- Equity €11.45bn Profit of €290.9m in 2025 (profit of €315.2m in 2024)Sourceaccounts 202513.99%
- Equity €4.98bn Profit of €151.2m in 2025 (profit of €279.8m in 2024)Sourceaccounts 202512.75%
- Equity €12.9m Profit of €3.0m in 2025 (profit of €3.1m in 2024) Checked scoreSourceaccounts 30-06-20252.34%
- Equity €23.6m Profit of €444,711 in 2025 (profit of €16.6m in 2024) Checked scoreSourceaccounts 20250.7%
Capital transactions
Shareholders according to the deeds
After 4 capital increases
deed of 23-02-2022 ↗
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
- créance certaine,liquide et exigible conjointe
Stated in the deed
deed of 23-02-2022 ↗
- 563 shares
After 2 capital increases
deed of 13-09-2018 ↗
After 3 capital increases
deed of 27-07-2017 ↗
- 5,750 shares
- 4,375 shares
- 625 shares
- 625 shares
- 6,250 shares
- 2,500 shares
- 625 shares
- 3,375 shares
- 375 shares
- 250 shares
- 250 shares
- 3,375 shares
Share transfer
deed of 27-07-2017 ↗
- to 3,375 shares
After the capital increase
deed of 05-01-2015 ↗
- 5,000 shares
- 6,666 shares
- 833 shares
- 834 shares
Show 2 older mentions
After 4 capital increases
deed of 10-12-2013 ↗
- créance (Promissory Note)
At incorporation
deed of 04-08-2010 ↗
- 19,999 shares (100%)
- 1 share (0%)
Capital over time
- 30-06-2026 Capital increase of €1,500,000 · to €84,277,306.56 · 44,117 new shares at €34 per share · in cash
- 20-05-2026 Capital increase of €1,000,000 · to €49,141,860.16 · 29,411 new shares at €34 per share · in cash
- 20-05-2026 Capital increase of €502,082.20 · to €49,643,942.36 · 21,094 new shares · “apport de créance certaine,liquide et exigible par Apporteurs Privilégiés”
- 20-05-2026 Capital increase of €2,020.20 · to €49,645,962.36 · 202,020 new shares · in cash
- 20-05-2026 Capital increase of €33,131,344 · to €82,777,306.56 · 974,451 new shares · “apport par Apporteurs Ordinaires d’une créance certaine,liquide et exigible détenue chacun respectivement à l’encontre de la Société”
- 09-01-2026 Capital increase of €3,057,487 · to €48,141,860.16 · 277,953 new shares at €11 per share · in cash
- 28-11-2025 Capital increase of €1,033,105 · 93,918 new shares · in cash
- 28-11-2025 Capital increase of €57,060 · 563 new shares · in cash
Show 30 older capital entries
- 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares at €11 per share · in cash
- 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares at €11 per share · in cash
- 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares
- 02-03-2023 Capital increase of €31,356 · to €41,994,208.16 · 603 new shares at €52 per share · in cash
- 08-08-2022 Capital increase of €41,031,652.98 · to €41,962,852.16 · in cash
- 23-02-2022 Capital increase of €1,731.22 · 563 new shares
- 23-02-2022 Capital increase of €76,868.85 · to €773,439.38 · 24,998 new shares · “apport créance certaine,liquide et exigible”
- 23-02-2022 Capital increase of €156,028.58 · to €929,467.96 · 50,741 new shares · in cash
- 18-11-2021 Capital stated in the deed · €696,570.53 · 226,527 shares
- 30-08-2021 Capital increase of €230.63 · to €696,570.53 · 75 new shares · in cash
- 02-09-2019 Capital increase · 38,000 new shares · conversion de 38000 droits de souscription
- 02-09-2019 Capital increase · to €696,339.90 · 87,500 new shares, 38.6% of the 226,452 shares after the increase
- 02-09-2019 Capital increase · 87,500 new shares · in cash
- 13-09-2018 Capital increase of €7,700,000 · to €8,006,845.02 · no new shares · from reserves
- 13-09-2018 Capital reduction of €7,700,000 · to €306,845.02 · to absorb losses
- 13-09-2018 Capital increase · to €310,427.40 · 1,165 new shares
- 27-07-2017 Capital increase of €76,875 · to €306,845.02 · 25,000 new shares, 25.1% of the 99,787 shares after the increase · in cash
- 27-07-2017 Capital increase of €5,000,000 · 25,000 new shares
- 27-07-2017 Capital increase of €76,875 · to €306,845.02 · 25,000 new shares
- 09-12-2016 Capital reduction of €6,430,000 · to €229,970.02 · to absorb losses
- 09-12-2016 Capital increase of €6,430,000 · no new shares · from reserves
- 15-04-2016 Capital increase of €10,000,000 · 50,000 new shares at €200 per share · in cash
- 15-04-2016 Capital increase of €5,000,000 · 25,000 new shares at €200 per share · in cash
- 15-04-2016 Capital increase of €5,000,000 · 25,000 new shares at €200 per share
- 05-01-2015 Capital increase · 13,333 new shares
- 10-12-2013 Capital increase · 3,120 new shares · in kind
- 10-12-2013 Capital increase · 26,667 new shares · in cash
- 10-12-2013 Capital increase · 13,334 new shares · in cash
- 10-12-2013 Capital increase · 13,333 new shares
- 04-08-2010 Incorporation · €61,500 · 20,000 shares
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off5 other companies of this director went bankrupt (2011, 2017, 2021, 2022, 2025).
- bankruptcy on 29-12-2025appointed in 2021, in office until the bankruptcy
- bankruptcy on 02-06-2022appointed in 2015, in office until the bankruptcy
- bankruptcy on 28-10-2021appointed in 2013, in office until the bankruptcy
- bankruptcy on 10-04-2017appointed in 2012, in office until the bankruptcy
- bankruptcy on 27-09-2011appointed in 2010, in office until the bankruptcy
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.